Results 1 to 10 of about 883,314 (350)
Microcirculatory dysfunction in cardiogenic shock
Annals of Intensive Care, 2023 Cardiogenic shock is usually defined as primary cardiac dysfunction with low cardiac output leading to critical organ hypoperfusion, and tissue hypoxia, resulting in high mortality rate between 40% and 50% despite recent advances.
Hamid Merdji +5 more
doaj +2 more sources
Arquivos Brasileiros de Cardiologia, 1999 To review the cause, epidemiology, pathophysiology, and treatment of cardiogenic shock.A MEDLINE search of the English-language reports published between 1976 and 1998 and a manual search of bibliographies of relevant papers.Experimental, clinical, and basic research studies related to cardiogenic shock.Data in selected articles were reviewed, and ...
Elias Knobel
doaj +6 more sources
A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock
Clinical Medicine Insights: Cardiology, 2022 This is a focused review looking at the pharmacological support in cardiogenic shock. There are a plethora of data evaluating vasopressors and inotropes in septic shock, but the data are limited for cardiogenic shock.
Aditi Shankar +6 more
doaj +2 more sources
Majalah Kardiologi Indonesia, 2023 : Cardiogenic shock (CS) is the most common cause of death in hospitalized patients with acute myocardial infarction (AMI). The incidence and mortality of CS in hospitals is also high, although advanced therapy is widely used in CS patients.
hendry purnasidha bagaswoto
doaj +2 more sources
Pediatric Emergency Medicine Journal, 2020 Cardiogenic shock is an acute circulatory failure due to compromised myocardial contractility associated with congenital heart diseases and cardiomyopathies, such as myocarditis. In this article, the authors present a 3-step overview of cardiogenic shock
Sungkyu Cho, Sang-Yun Lee
doaj +3 more sources
Mechanical circulatory support in cardiogenic shock
Journal of Intensive Care, 2023 Cardiogenic shock is a complex and diverse pathological condition characterized by reduced myocardial contractility. The goal of treatment of cardiogenic shock is to improve abnormal hemodynamics and maintain adequate tissue perfusion in organs.
Jun Nakata +5 more
doaj +2 more sources
ESC Heart Failure, 2021 Aim The management of cardiogenic shock remains a clinical challenge even in well‐developed healthcare systems, best illustrated by its high mortality despite numerous innovative proposals for management.
Benedikt Schrage +12 more
doaj +2 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019 Cyrus Vahdatpour +2 more
doaj +6 more sources
Phenotyping Cardiogenic Shock [PDF]
Journal of the American Heart Association, 2021 Background Cardiogenic shock (CS) is a heterogeneous syndrome with varied presentations and outcomes. We used a machine learning approach to test the hypothesis that patients with CS have distinct phenotypes at presentation, which are associated with unique clinical profiles and in‐hospital mortality.
Shashank S. Sinha +26 more
openaire +7 more sources